{
  "url": "https://en.wikipedia.org/wiki/List_of_largest_pharmaceutical_settlements",
  "title": "List of largest pharmaceutical settlements",
  "header": [
    [
      "Year",
      []
    ],
    [
      "Company",
      []
    ],
    [
      "Settlement",
      []
    ],
    [
      "Violation ( s )",
      []
    ],
    [
      "Product ( s )",
      []
    ],
    [
      "Laws allegedly violated ( if applicable )",
      []
    ]
  ],
  "data": [
    [
      [
        "2012",
        []
      ],
      [
        "GlaxoSmithKline",
        [
          "/wiki/GlaxoSmithKline"
        ]
      ],
      [
        "$ 3 billion ( $ 1B criminal , $ 2B civil )",
        []
      ],
      [
        "Criminal : Off-label promotion , failure to disclose safety data . Civil : paying kickbacks to physicians , making false and misleading statements concerning the safety of Avandia , reporting false best prices and underpaying rebates owed under the Medicaid Drug Rebate Program",
        [
          "/wiki/Medicaid_Drug_Rebate_Program"
        ]
      ],
      [
        "Avandia ( not providing safety data ) , Wellbutrin , Paxil ( promotion of paediatric use ) , Advair , Lamictal , Zofran , Imitrex , Lotronex , Flovent , Valtrex ;",
        [
          "/wiki/Rosiglitazone",
          "/wiki/Bupropion",
          "/wiki/Paroxetine",
          "/wiki/Advair",
          "/wiki/Lamictal",
          "/wiki/Zofran",
          "/wiki/Imitrex",
          "/wiki/Lotronex",
          "/wiki/Flovent",
          "/wiki/Valtrex"
        ]
      ],
      [
        "False Claims Act / FDCA",
        [
          "/wiki/False_Claims_Act",
          "/wiki/Federal_Food,_Drug,_and_Cosmetic_Act"
        ]
      ]
    ],
    [
      [
        "2009",
        []
      ],
      [
        "Pfizer",
        [
          "/wiki/Pfizer"
        ]
      ],
      [
        "$ 2.3 billion",
        []
      ],
      [
        "Off-label promotion/ kickbacks",
        [
          "/wiki/Kickback_(bribery)"
        ]
      ],
      [
        "Bextra / Geodon / Zyvox / Lyrica",
        [
          "/wiki/Valdecoxib",
          "/wiki/Ziprasidone",
          "/wiki/Linezolid",
          "/wiki/Pregabalin"
        ]
      ],
      [
        "False Claims Act/FDCA",
        []
      ]
    ],
    [
      [
        "2013",
        []
      ],
      [
        "Johnson & Johnson",
        [
          "/wiki/Johnson_&_Johnson"
        ]
      ],
      [
        "$ 2.2 billion",
        []
      ],
      [
        "Off-label promotion/ kickbacks",
        [
          "/wiki/Kickback_(bribery)"
        ]
      ],
      [
        "Risperdal / Invega / Nesiritide",
        [
          "/wiki/Risperidone",
          "/wiki/Paliperidone",
          "/wiki/Nesiritide"
        ]
      ],
      [
        "False Claims Act/FDCA",
        []
      ]
    ],
    [
      [
        "2012",
        []
      ],
      [
        "Abbott Laboratories",
        [
          "/wiki/Abbott_Laboratories"
        ]
      ],
      [
        "$ 1.5 billion",
        []
      ],
      [
        "Off-label promotion",
        []
      ],
      [
        "Depakote",
        [
          "/wiki/Valproic_acid"
        ]
      ],
      [
        "False Claims Act/FDCA",
        []
      ]
    ],
    [
      [
        "2009",
        []
      ],
      [
        "Eli Lilly",
        [
          "/wiki/Eli_Lilly_and_Company"
        ]
      ],
      [
        "$ 1.4 billion",
        []
      ],
      [
        "Off-label promotion",
        []
      ],
      [
        "Zyprexa",
        [
          "/wiki/Olanzapine"
        ]
      ],
      [
        "False Claims Act/FDCA",
        []
      ]
    ],
    [
      [
        "2001",
        []
      ],
      [
        "TAP Pharmaceutical Products",
        [
          "/wiki/TAP_Pharmaceutical_Products"
        ]
      ],
      [
        "$ 875 million",
        []
      ],
      [
        "Medicare fraud /kickbacks",
        [
          "/wiki/Medicare_fraud"
        ]
      ],
      [
        "Lupron",
        [
          "/wiki/Leuprorelin"
        ]
      ],
      [
        "False Claims Act/ Prescription Drug Marketing Act",
        [
          "/wiki/Prescription_Drug_Marketing_Act"
        ]
      ]
    ],
    [
      [
        "2012",
        []
      ],
      [
        "Amgen",
        [
          "/wiki/Amgen"
        ]
      ],
      [
        "$ 762 million",
        []
      ],
      [
        "Off-label promotion/kickbacks",
        []
      ],
      [
        "Aranesp",
        [
          "/wiki/Aranesp"
        ]
      ],
      [
        "False Claims Act/FDCA",
        []
      ]
    ],
    [
      [
        "2010",
        []
      ],
      [
        "GlaxoSmithKline",
        []
      ],
      [
        "$ 750 million",
        []
      ],
      [
        "Poor manufacturing practices",
        []
      ],
      [
        "Kytril / Bactroban / Paxil CR / Avandamet",
        [
          "/wiki/Granisetron",
          "/wiki/Mupirocin",
          "/wiki/Paroxetine",
          "/wiki/Metformin"
        ]
      ],
      [
        "False Claims Act/FDCA",
        []
      ]
    ],
    [
      [
        "2005",
        []
      ],
      [
        "Serono",
        [
          "/wiki/Serono"
        ]
      ],
      [
        "$ 704 million",
        []
      ],
      [
        "Off-label promotion/ kickbacks/ monopoly practices",
        [
          "/wiki/Monopoly"
        ]
      ],
      [
        "Serostim",
        [
          "/wiki/Serostim"
        ]
      ],
      [
        "False Claims Act",
        []
      ]
    ],
    [
      [
        "2008",
        []
      ],
      [
        "Merck",
        [
          "/wiki/Merck_&_Co."
        ]
      ],
      [
        "$ 650 million",
        []
      ],
      [
        "Medicare fraud/kickbacks",
        []
      ],
      [
        "Zocor / Vioxx / Pepsid",
        [
          "/wiki/Simvastatin",
          "/wiki/Rofecoxib",
          "/wiki/Famotidine"
        ]
      ],
      [
        "False Claims Act/ Medicaid Rebate Statute",
        []
      ]
    ],
    [
      [
        "2007",
        []
      ],
      [
        "Purdue Pharma",
        [
          "/wiki/Purdue_Pharma"
        ]
      ],
      [
        "$ 601 million",
        []
      ],
      [
        "Off-label promotion",
        []
      ],
      [
        "Oxycontin",
        [
          "/wiki/Oxycontin"
        ]
      ],
      [
        "False Claims Act",
        []
      ]
    ],
    [
      [
        "2010",
        []
      ],
      [
        "Allergan",
        [
          "/wiki/Allergan"
        ]
      ],
      [
        "$ 600 million",
        []
      ],
      [
        "Off-label promotion",
        []
      ],
      [
        "Botox",
        [
          "/wiki/Botulinum_toxin"
        ]
      ],
      [
        "False Claims Act/FDCA",
        []
      ]
    ],
    [
      [
        "2010",
        []
      ],
      [
        "AstraZeneca",
        [
          "/wiki/AstraZeneca"
        ]
      ],
      [
        "$ 520 million",
        []
      ],
      [
        "Off-label promotion/kickbacks",
        []
      ],
      [
        "Seroquel",
        [
          "/wiki/Quetiapine"
        ]
      ],
      [
        "False Claims Act",
        []
      ]
    ],
    [
      [
        "2007",
        []
      ],
      [
        "Bristol-Myers Squibb",
        [
          "/wiki/Bristol-Myers_Squibb"
        ]
      ],
      [
        "$ 515 million",
        []
      ],
      [
        "Off-label promotion/ kickbacks/Medicare fraud",
        []
      ],
      [
        "Abilify / Serzone",
        [
          "/wiki/Aripiprazole",
          "/wiki/Nefazodone"
        ]
      ],
      [
        "False Claims Act/FDCA",
        []
      ]
    ],
    [
      [
        "2002",
        []
      ],
      [
        "Schering-Plough",
        [
          "/wiki/Schering-Plough"
        ]
      ],
      [
        "$ 500 million",
        []
      ],
      [
        "Poor manufacturing practices",
        []
      ],
      [
        "Claritin",
        [
          "/wiki/Loratadine"
        ]
      ],
      [
        "FDA Current Good Manufacturing Practices",
        [
          "/wiki/Food_and_Drug_Administration",
          "/wiki/Good_manufacturing_practice"
        ]
      ]
    ],
    [
      [
        "2006",
        []
      ],
      [
        "Mylan",
        [
          "/wiki/Mylan"
        ]
      ],
      [
        "$ 465 million",
        []
      ],
      [
        "Misclassification under the Medicaid Drug Rebate Program",
        [
          "/wiki/Medicaid_Drug_Rebate_Program"
        ]
      ],
      [
        "EpiPen ( epinephrine )",
        [
          "/wiki/EpiPen",
          "/wiki/Epinephrine"
        ]
      ],
      [
        "False Claims Act",
        [
          "/wiki/False_Claims_Act"
        ]
      ]
    ],
    [
      [
        "2006",
        []
      ],
      [
        "Schering-Plough",
        []
      ],
      [
        "$ 435 million",
        []
      ],
      [
        "Off-label promotion/ kickbacks/Medicare fraud",
        []
      ],
      [
        "Temodar / Intron A / K-Dur / Claritin RediTabs",
        [
          "/wiki/Temozolomide",
          "/wiki/Interferon_alfa-2b",
          "/wiki/Potassium_chloride",
          "/wiki/Loratadine"
        ]
      ],
      [
        "False Claims Act/FDCA",
        []
      ]
    ],
    [
      [
        "2004",
        []
      ],
      [
        "Pfizer",
        []
      ],
      [
        "$ 430 million",
        []
      ],
      [
        "Off-label promotion",
        []
      ],
      [
        "Neurontin",
        [
          "/wiki/Gabapentin"
        ]
      ],
      [
        "False Claims Act/FDCA",
        []
      ]
    ],
    [
      [
        "2008",
        []
      ],
      [
        "Cephalon",
        [
          "/wiki/Cephalon"
        ]
      ],
      [
        "$ 425 million",
        []
      ],
      [
        "Off-label promotion",
        []
      ],
      [
        "Actiq / Gabitril / Provigil",
        [
          "/wiki/Actiq",
          "/wiki/Tiagabine",
          "/wiki/Modafinil"
        ]
      ],
      [
        "False Claims Act/FDCA",
        []
      ]
    ],
    [
      [
        "2010",
        []
      ],
      [
        "Novartis",
        [
          "/wiki/Novartis"
        ]
      ],
      [
        "$ 423 million",
        []
      ],
      [
        "Off-label promotion/kickbacks",
        []
      ],
      [
        "Trileptal",
        [
          "/wiki/Oxcarbazepine"
        ]
      ],
      [
        "False Claims Act/FDCA",
        []
      ]
    ]
  ],
  "section_title": "",
  "section_text": "The following is a list of the 20 largest settlements reached between the United States Department of Justice and pharmaceutical companies from 1991 to 2012 , ordered by the size of the total settlement . The settlement amount includes both the civil ( False Claims Act ) settlement and criminal fine . Glaxo 's $ 3 billion settlement included the largest civil , False Claims Act settlement on record , [ 1 ] and Pfizer \u2019 s $ 2.3 billion settlement including a record-breaking $ 1.3 billion criminal fine . [ 2 ] Legal claims against the pharmaceutical industry have varied widely over the past two decades , including Medicare and Medicaid fraud , off-label promotion , and inadequate manufacturing practices . [ 3 ] [ 4 ] With respect to off-label promotion , specifically , a federal court recognized off-label promotion as a violation of the False Claims Act for the first time in Franklin v. Parke-Davis , leading to a $ 430 million settlement . [ 5 ]",
  "uid": "List_of_largest_pharmaceutical_settlements_0"
}